Lipella Pharmaceuticals Files 8-K

Ticker: LIPO · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1347242

Lipella Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyLipella Pharmaceuticals Inc. (LIPO)
Form Type8-K
Filed DateJun 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, SEC Filing, Regulation FD

TL;DR

Lipella Pharma filed an 8-K on 6/25/25, more details to come.

AI Summary

Lipella Pharmaceuticals Inc. filed an 8-K on June 25, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' beyond its classification.

Why It Matters

This 8-K filing indicates Lipella Pharmaceuticals Inc. is providing updates to the SEC, though the specific details of these updates are not immediately clear from the provided header information.

Risk Assessment

Risk Level: low — The filing is a standard 8-K notification without immediate disclosed financial impact or significant corporate events.

Key Players & Entities

  • Lipella Pharmaceuticals Inc. (company) — Registrant
  • June 25, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Pittsburgh, PA (location) — Principal executive office location
  • (412) 894-1853 (phone_number) — Registrant's telephone number

FAQ

What specific 'Other Events' are being reported by Lipella Pharmaceuticals Inc. in this 8-K filing?

The provided filing header does not specify the details of the 'Other Events' beyond listing it as an item of information.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 25, 2025.

What is the principal executive office address for Lipella Pharmaceuticals Inc.?

The principal executive office address for Lipella Pharmaceuticals Inc. is 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.

In which state is Lipella Pharmaceuticals Inc. incorporated?

Lipella Pharmaceuticals Inc. is incorporated in Delaware.

What is the telephone number for Lipella Pharmaceuticals Inc.?

The telephone number for Lipella Pharmaceuticals Inc. is (412) 894-1853.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding LIPELLA PHARMACEUTICALS INC. (LIPO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.